US Patent Issued to Dana-Farber Cancer Institute on June 9 for "Vaccine compositions and methods for restoring NKG2D pathway function against cancers" (Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. RE50,908, issued on June 9, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Vaccine compositions and methods for restoring NKG2D pathway function against cancers" was invented by Glenn Dranoff (Sudbury, Mass.), Kai W. Wucherpfennig (Brookline, Mass.), Christopher Harvey (Boston) and F. Stephen Hodi (Framingham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treating cancer in a subject by eliciting an immune response against a MIC polypeptide."

The patent was filed on May 7, 2021, under Application No. 17/314,828.

*For further information, including images, charts and tables, p...